Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire

Emily Mathey, C. Breithaupt, Christopher Linington, A. S. Schubart

    Research output: Contribution to journalEditorial

    26 Citations (Scopus)

    Abstract

    Myelin oligodendrocyte glycoprotein (MOG) is the only myelin protein known to initiate a demyelinating autoantibody response in EAE, an animal model for multiple sclerosis (MS). The pathophysiological significance of MOG-specific autoantibodies in MS is, however, controversial, as high titer antibody responses to MOG are also found in many patients with non-demyelinating neurological diseases. In this issue of the European Journal of Immunology, von Budingen et al. demonstrate that demyelination in a primate model of MOG-induced EAE is mediated by MOG-specific antibodies directed against discontinuous, rather than linear, MOG epitopes. This functional segregation of pathogenic vs. non-pathogenic autoantibodies in terms of epitope specificity may be crucial to understand the relevance of MOG-specific responses in human disease. This commentary discusses these findings in the context of the structure and immunobiology of MOG, and their implications with respect to antibody-mediated demyelination in MS.

    Original languageEnglish
    Pages (from-to)2065-2071
    Number of pages6
    JournalEuropean Journal of Immunology
    Volume34
    Issue number8
    DOIs
    Publication statusPublished - 2004

    Keywords

    • B cells
    • demyelination
    • multiple sclerosis
    • experimental autoimmune encephalomyelitis
    • EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
    • EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
    • MULTIPLE-SCLEROSIS PATHOLOGY
    • ANTIGEN-SPECIFIC ANTIBODY
    • B-CELL RESPONSES
    • MOG-INDUCED EAE
    • MYELIN/OLIGODENDROCYTE GLYCOPROTEIN
    • BASIC-PROTEIN
    • T-CELL
    • MONOCLONAL-ANTIBODY

    Cite this

    Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire. / Mathey, Emily; Breithaupt, C.; Linington, Christopher; Schubart, A. S.

    In: European Journal of Immunology, Vol. 34, No. 8, 2004, p. 2065-2071.

    Research output: Contribution to journalEditorial

    @article{cdfe291598e844da8ea3e41b81b4d281,
    title = "Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire",
    abstract = "Myelin oligodendrocyte glycoprotein (MOG) is the only myelin protein known to initiate a demyelinating autoantibody response in EAE, an animal model for multiple sclerosis (MS). The pathophysiological significance of MOG-specific autoantibodies in MS is, however, controversial, as high titer antibody responses to MOG are also found in many patients with non-demyelinating neurological diseases. In this issue of the European Journal of Immunology, von Budingen et al. demonstrate that demyelination in a primate model of MOG-induced EAE is mediated by MOG-specific antibodies directed against discontinuous, rather than linear, MOG epitopes. This functional segregation of pathogenic vs. non-pathogenic autoantibodies in terms of epitope specificity may be crucial to understand the relevance of MOG-specific responses in human disease. This commentary discusses these findings in the context of the structure and immunobiology of MOG, and their implications with respect to antibody-mediated demyelination in MS.",
    keywords = "B cells, demyelination, multiple sclerosis, experimental autoimmune encephalomyelitis, EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, MULTIPLE-SCLEROSIS PATHOLOGY, ANTIGEN-SPECIFIC ANTIBODY, B-CELL RESPONSES, MOG-INDUCED EAE, MYELIN/OLIGODENDROCYTE GLYCOPROTEIN, BASIC-PROTEIN, T-CELL, MONOCLONAL-ANTIBODY",
    author = "Emily Mathey and C. Breithaupt and Christopher Linington and Schubart, {A. S.}",
    year = "2004",
    doi = "10.1002/eji.200425291",
    language = "English",
    volume = "34",
    pages = "2065--2071",
    journal = "European Journal of Immunology",
    issn = "0014-2980",
    publisher = "Wiley-VCH Verlag",
    number = "8",

    }

    TY - JOUR

    T1 - Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire

    AU - Mathey, Emily

    AU - Breithaupt, C.

    AU - Linington, Christopher

    AU - Schubart, A. S.

    PY - 2004

    Y1 - 2004

    N2 - Myelin oligodendrocyte glycoprotein (MOG) is the only myelin protein known to initiate a demyelinating autoantibody response in EAE, an animal model for multiple sclerosis (MS). The pathophysiological significance of MOG-specific autoantibodies in MS is, however, controversial, as high titer antibody responses to MOG are also found in many patients with non-demyelinating neurological diseases. In this issue of the European Journal of Immunology, von Budingen et al. demonstrate that demyelination in a primate model of MOG-induced EAE is mediated by MOG-specific antibodies directed against discontinuous, rather than linear, MOG epitopes. This functional segregation of pathogenic vs. non-pathogenic autoantibodies in terms of epitope specificity may be crucial to understand the relevance of MOG-specific responses in human disease. This commentary discusses these findings in the context of the structure and immunobiology of MOG, and their implications with respect to antibody-mediated demyelination in MS.

    AB - Myelin oligodendrocyte glycoprotein (MOG) is the only myelin protein known to initiate a demyelinating autoantibody response in EAE, an animal model for multiple sclerosis (MS). The pathophysiological significance of MOG-specific autoantibodies in MS is, however, controversial, as high titer antibody responses to MOG are also found in many patients with non-demyelinating neurological diseases. In this issue of the European Journal of Immunology, von Budingen et al. demonstrate that demyelination in a primate model of MOG-induced EAE is mediated by MOG-specific antibodies directed against discontinuous, rather than linear, MOG epitopes. This functional segregation of pathogenic vs. non-pathogenic autoantibodies in terms of epitope specificity may be crucial to understand the relevance of MOG-specific responses in human disease. This commentary discusses these findings in the context of the structure and immunobiology of MOG, and their implications with respect to antibody-mediated demyelination in MS.

    KW - B cells

    KW - demyelination

    KW - multiple sclerosis

    KW - experimental autoimmune encephalomyelitis

    KW - EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

    KW - EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

    KW - MULTIPLE-SCLEROSIS PATHOLOGY

    KW - ANTIGEN-SPECIFIC ANTIBODY

    KW - B-CELL RESPONSES

    KW - MOG-INDUCED EAE

    KW - MYELIN/OLIGODENDROCYTE GLYCOPROTEIN

    KW - BASIC-PROTEIN

    KW - T-CELL

    KW - MONOCLONAL-ANTIBODY

    U2 - 10.1002/eji.200425291

    DO - 10.1002/eji.200425291

    M3 - Editorial

    VL - 34

    SP - 2065

    EP - 2071

    JO - European Journal of Immunology

    JF - European Journal of Immunology

    SN - 0014-2980

    IS - 8

    ER -